Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
European Journal of Cancer · 2025-03 · 218 · 115275
DOI: 10.1016/j.ejca.2025.115275 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2025-03. Verfasst von Karin P S Langenberg und 38 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: k.p.s.langenberg@prinsesmaxim…. Hauptthemen laut MEDLINE: Neuroblastoma, Precision Medicine, Organoids, High-Throughput Screening Assays. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, Bundesministerium für Gesundheit.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: k.p.s.langenberg@prinsesmaximacentrum.nl.
- Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: s.r.vanhooff-3@prinsesmaximacentrum.nl.
- Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: B.Koopmans@prinsesmaximacentrum.nl.
- Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: J.G.M.Strijker@prinsesmaximacentrum.nl.
- Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: w.kholosy@amsterdamumc.nl.
- Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: k.ober@erasmusmc.nl.
Förderung
- Deutsche Krebshilfe
- Deutsches Krebsforschungszentrum
- Bundesministerium für Gesundheit
- HORIZON EUROPE European Research Council
- Horizon 2020
- Children Cancer Free Foundation
- Bundesministerium für Bildung und Forschung
- Deutschen Konsortium für Translationale Krebsforschung
Zitieren
APA
Langenberg, K. P. S., van Hooff, S. R., Koopmans, B., Strijker, J. G. M., Kholosy, W. M., Ober, K., Zwijnenburg, D. A., van der Hoek, J. J. F., Keller, K. M., Vernooij, L., Schild, L. G., Looze, E. J., Ebus, M. E., Essing, A. H. W., Vree, P., Tas, M. L., Matser, Y. A. H., Wienke, J., Volckmann, R., …, & Molenaar, J. J. (2025). Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine. European Journal of Cancer, 218, 115275. https://doi.org/10.1016/j.ejca.2025.115275
Vancouver
Langenberg KPS, van Hooff SR, Koopmans B, Strijker JGM, Kholosy WM, Ober K, et al. Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine. European Journal of Cancer. 2025;218:115275. doi:10.1016/j.ejca.2025.115275
BibTeX
@article{Langenberg2025,
author = {Langenberg, Karin P S and van Hooff, Sander R and Koopmans, Bianca and Strijker, Josephine G M and Kholosy, Waleed M and Ober, Kimberley and Zwijnenburg, Danny A and van der Hoek, Jessica J F and Keller, Kaylee M and Vernooij, Lindy and Schild, Linda G and Looze, Eleonora J and Ebus, Marli E and Essing, Anke H W and Vree, Paula de and Tas, Michelle L and Matser, Yvette A H and Wienke, Judith and Volckmann, Richard and Tops, Bastiaan B J and Kester, Lennart A and Badloe, Shashi and Hehir-Kwa, Jayne Y and Kemmeren, Patrick and Goemans, Bianca F and Zwaan, C Michel and Oehme, Ina and Jäger, Nathalie and Witt, Olaf and van Eijkelenburg, Natasha K A and Dierselhuis, Miranda P and Tytgat, Godelieve A M and Wijnen, Marc H W and van Noesel, Max M and de Krijger, Ronald R and Eising, Selma and Koster, Jan and Dolman, Emmy M and Molenaar, Jan J},
title = {Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine},
journal = {European Journal of Cancer},
year = {2025},
volume = {218},
pages = {115275},
doi = {10.1016/j.ejca.2025.115275}
}
EUVIMED